News Room

Group of finalists leading innovations in medicine and MS treatment

BeCareLink Recognized for Innovation in Multiple Sclerosis

Congratulations again to the 2019 “Addressing Unmet Needs in MS: An Innovation Challenge” finalists.


The ten finalists, including BeCare Link, were recognized as outstanding patient entrepreneurs. These companies are developing innovations in medicine and solutions to address an unmet need in treating multiple sclerosis. Celgene was so inspired by the companies, that we will award each of the remaining finalists $10,000 to help develop their potential solutions! Celgene was so inspired by the companies, that we will award each of the remaining finalists $10,000 to help develop their potential solutions!

Read more about the innovations under development along with BeCare Link’s digital therapeutics platform by clicking on the button below.